The import of composite diagnostic or laboratory reagents to Mexico has shown varied trends over recent years. Between 2013 and 2015, the values initially increased, reaching a peak in 2014, before experiencing a steep decline in 2015. From 2016 to 2020, the values fluctuated slightly but generally trended downward. A recovery trend began in 2018, and from 2020 onwards, the imports have consistently increased year-on-year. As of 2023, the imports stood at 333.36 million USD. The average year-on-year percentage variation over the last two years (2022-2023) was 1.82%, and the CAGR for the past five years (2019-2023) averaged 2.85%.
- 2013: 8.55% YoY increase, 8.76% CAGR
- 2014: 6.61% YoY increase, 9.92% CAGR
- 2015: -15.92% YoY decrease, 5.6% CAGR
- 2016: -2.17% YoY decrease, -0.29% CAGR
- 2017: -2.48% YoY decrease, -1.48% CAGR
- 2018: 7.01% YoY increase, -1.76% CAGR
- 2019: 1.52% YoY increase, -2.72% CAGR
- 2020: 2.01% YoY increase, 1.12% CAGR
- 2021: 1.93% YoY increase, 1.96% CAGR
- 2022: 1.86% YoY increase, 2.85% CAGR
- 2023: 1.79% YoY increase, 1.82% CAGR (value: 333.36 million USD)
Looking forward, imports are expected to continue growing, with a forecasted CAGR of 1.26% over the next five years. By 2028, the import value is projected to reach approximately 360.96 million USD. Future trends to watch include potential impacts from technological advancements in diagnostic tools, regulatory changes, and shifts in global supply chain dynamics.
